Moderna on Tuesday announced that its vaccine targeting respiratory syncytial virus (RSV) was nearly 84% effective in a clinical trial of older adults, adding another RSV vaccine to the pipeline of candidates for potential FDA approval.
Across the United States, flu activity remains high in several regions, but is beginning to decline in many areas. However, the ongoing circulation of various respiratory viruses, including COVID-19 and respiratory syncytial virus, is contributing to a "perfect storm for co-infections." See where your state stands on our interactive map.
It's been nearly three years since many Americans started to work from home (WFH), and many may need a change in their routine. Writing for the Harvard Business Review, time-management coach Elizabeth Grace Saunders explains why you may want to change your WFH routine and how to do it.
Harvard Medical School has withdrawn from U.S. News & World Report's annual rankings of the "best medical schools," in today's bite-sized hospital and health industry news from the District of Columbia, Massachusetts, and New York.
Print All Daily Briefing Article from
Have a Question?
Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.